Quantcast

Latest left bundle branch block Stories

2014-06-24 10:06:57

The JAMA Network Journals Bottom Line: Cardiac resynchronization therapy plus defibrillator implantation (CRT-D) sometimes helps women with heart failure more than men, although women are less likely to receive CRT-D than men. Author: Robbert Zusterzeel, M.D., and colleagues at the Center for Devices and Radiological Health at the U.S. Food and Drug Administration, Silver Spring, Md. Background: Women are underrepresented in CRT trials for heart failure, making up only about 20...

2013-08-14 12:15:27

In a large population of Medicare beneficiaries with heart failure who underwent implantation of a cardiac resynchronization therapy defibrillator, patients who had the cardiac characteristics of left bundle-branch block and longer QRS duration had the lowest risks of death and all-cause, cardiovascular, and heart failure readmission, according to a study in the August 14 issue of JAMA. "Clinical trials have shown that cardiac resynchronization therapy (CRT) improves symptoms and reduces...

2013-04-17 13:20:36

UC San Francisco-led team uncovers potential risks to cardiac condition previously thought benign A common test that records the heart's electrical activity could predict potentially serious cardiovascular illness, according to a UC San Francisco-led study. A cardiac condition called left anterior fascicular block (LAFB), in which scarring occurs in a section of the left ventricle, may not be as benign as currently thought and could increase the likelihood of heart failure, sudden...

2011-08-19 04:00:00

BOTHELL, Wash., Aug. 19, 2011 /PRNewswire/ -- Verathon Inc. is pleased to introduce in Europe the Heartscape(TM) 3D ECG System with 80-lead vest, designed to give Emergency Department (ED) physicians, Interventional Cardiologists, and ED nurses a more complete diagnostic picture by providing a 360 degree electrocardiographic view of the heart. (Photo: http://photos.prnewswire.com/prnh/20110819/SF54845) (Logo: http://photos.prnewswire.com/prnh/20061011/SFW044LOGO) The Heartscape 3D ECG...

2011-03-02 02:08:54

Mild heart failure patients with a particular condition that results in disorganized electrical activity throughout the heart benefit substantially from cardiac resynchronization therapy with defibrillator (CRT"“D), according to a study published in the American Heart Association journal Circulation. In patients with the condition, known as left bundle branch block or LBBB, CRT-D therapy reduced heart failure progression and the risk of ventricular tachyarrhythmias, fast and potentially...

2010-09-16 16:09:00

NATICK, Mass., Sept. 16 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for its cardiac resynchronization therapy defibrillators (CRT-Ds), including the COGNIS® CRT-D. The exclusive expanded indication is effective immediately and makes Boston Scientific CRT-Ds the only devices approved by the FDA for patients in all New York Heart Association (NYHA)...

2010-09-16 15:13:00

SILVER SPRING, Md., Sept. 16 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved a new indication for three cardiac resynchronization therapy defibrillators (CRT-D) used to treat certain heart failure patients. The new use is for patients with an abnormality known as left bundle branch block, which occurs when there is delayed activation and contraction of the left ventricle. The three devices, all manufactured by Boston Scientific Corp., are intended to treat...

2010-09-08 07:00:00

SANTA CLARA, Calif., Sept. 8 /PRNewswire-FirstCall/ -- NewCardio (OTC Bulletin Board: NWCI) a cardiac diagnostic technology provider, announced today that a clinical study of the Cardio3KG(TM) in acute cardiac diagnosis has been published in the August 2010 issue of the peer-reviewed journal, Heart Rhythm, the official journal of the Heart Rhythm Society. The study, entitled "Vectorcardiographic and Electrocardiographic Criteria to Distinguish New and Old Left Bundle Branch Block," was led...

2010-06-18 06:02:00

NATICK, Massachusetts and NICE, France, June 18, 2010 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced results from a sub-analysis of the MADIT-CRT trial data that showed women received a greater clinical benefit from its cardiac resynchronization therapy defibrillators (CRT-Ds) than men. The results were presented during the 17th Cardiostim World Congress by Jonathan Steinberg, M.D., Chief of Cardiology and Director of the Al-Sabah Arrythmia Institute,...

2010-06-11 07:30:00

NATICK, Mass., June 11 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's key events and sponsored research at the 17th Cardiostim World Congress, June 16 - 19 in Nice, France. (All times are local; all events take place in the Nice Acropolis Convention Center unless otherwise indicated.) Sessions related to Boston Scientific's landmark MADIT-CRT heart failure trial: MADIT-CRT is the world's largest randomized study of New...


Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.